Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5351–5400 of 18416
the Company entered into a consulting agreement with Mr. Harshman (the “Harshman Consulting Agreement”), effective June 11, 2024, and ending on the one-year anniversary thereof, subject to any extension by mutual agreement between the parties.
On April 29, 2024, Cullinan Therapeutics, Inc. (the “Company”) announced the hiring and appointment of Mary Kay Fenton as the Company’s Chief Financial Officer, effective immediately.
On April 29, 2024, Flexsteel Industries, Inc. (the “Company”) announced the appointment of Derek P. Schmidt to the position of Chief Executive Officer effective on July 1, 2024.
Mr. Schmidt will succeed Jerald K. Dittmer who has announced his resignation from the position of Chief Executive Officer effective June 30, 2024, and retirement from the Company on December 31, 2024.
the Company appointed Sandra Campos, an existing director of the Company, as the Company’s new Chief Executive Officer and President.
Mr. Hulett resigned as President and Chief Executive Officer, and also as a director, of the Company effective April 29, 2024
On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.
current Deputy Chief Financial Officer Cindy Lee will succeed Sean Galvin as Chief Financial Officer effective August 1, 2024.
Mr. Galvin will remain with the Company in a senior role after the planned transition as of August 1, 2024.
appointed Thomas Leggett as the Chief Financial Officer of the Company
Resignation of Chief Financial Officer Effective as of the Appointment Date, the Company’s current Chief Financial Off
the Board has appointed William P. Stengel, II, as Chief Executive Officer of the Company, effective as of the Effective Date, such that following the Effective Date Mr. Stengel will hold the dual title of President and Chief Executive Officer of the Company.
appointed Nathan Schultz as the President and Chief Executive Officer ("CEO") of the Company, effective as of June 1, 2024
The Company also announced the planned retirement, as of the end of May, of P. Matthew Farabaugh, the Company’s Senior Vice President and Chief Financial Officer.
Bradley Taillon has been appointed as President and Chief Executive Officer, effective April 29, 2024.
On April 29, 2024, the Company appointed Bryant J. Reeves, III as the Company’s permanent Chief Financial Officer, effective April 29, 2024.
Effective April 29, 2024, Mr. Leach has agreed to continue to serve as the Company’s principal financial officer through June 30, 2024 or until such time a successor has been named, after which he will assist with the orderly transition of his responsibilities.
Effective May 3, 2024, the Board appointed Ronald Totton to serve as interim President and Chief Executive Officer until a permanent President and Chief Executive Officer has been appointed.
On April 29, 2024, KORE Group Holdings, Inc. (the “Company”) announced that the Company’s Board of Directors (the “Board”) and Romil Bahl, its President and Chief Executive Officer, had mutually agreed that Mr. Bahl would step down as President and Chief Executive Officer and a member of the Board, effective as of May 3, 2024.
On April 24, 2024, Michael H. Liu notified the board of directors (the “ Board ”) of Tristar Acquisition I Corp. (the “ Company ”) of his resignation as Chief Financial Officer and Director of the Company, effective on April 23, 2024.
On April 29, 2024, the directors of the Company appointed Chunyi (Charlie) Hao, the Company’s President and Chairman of the Board of Directors, as the Chief Financial Officer of the Company, effective on April 29, 2024.
On April 26, 2024, the Company disclosed that Roop K. Lakkaraju, the Company’s Executive Vice President and Chief Financial Officer (and principal financial officer) will act as the Company’s principal accounting officer.
Effective May 1, 2024, Mr. Birkett’s title will be solely Chief Financial Officer (“CFO”), where he will retain financial oversight for both Business Segments, operational oversight of our strategic sourcing function and be involved in key operational issues together with other members of our executive team.
Fannie Mae’s Board of Directors appointed Priscilla Almodovar to succeed Mr. Benson as President in addition to her role as Chief Executive Officer.
On April 23, 2024, Cytokinetics, Incorporated (the “Company”) entered into an employment offer letter (the “Offer Letter”) with Sung H. Lee, pursuant to which Mr. Lee has agreed to serve as the Company’s Executive Vice President (“EVP”), Chief Financial Officer, effective as of May 8, 2024 (the “Start Date”).
On April 23, 2024, Mr. Douglas L. Col, Executive Vice President and Chief Financial Officer, informed Saia, Inc. of his plans to retire after 10 years of service, including the last four years as Chief Financial Officer.
David W. Grzebinski’s title changed to Chief Executive Officer.
Mr. McKilligan will remain as Chief Financial Officer of Graphium Biosciences, Inc., a wholly-owned subsidiary of the Company (“Graphium”).
On April 25, 2024, the Board of Directors of Range Impact, Inc. (the “Company”) elected Patricia Missal as Chief Financial Officer, replacing Richard McKilligan who had previously served as the Company’s Chief Financial Officer, Counsel and Secretary.
On April 16, 2024, Darrell L. Peterson, the Chief Executive Officer and President and a Director of InnovaQor, Inc. (the “Company”) and certain subsidiaries, resigned from these positions.
The Company is currently conducting a search for a successor to Mr. Peterson and has appointed Justin Doherty, a Director of the Company, as Interim Chief Executive Officer until a successor is found.
Robert Powers, the Company’s Chief Financial Officer, will now also serve as principal accounting officer.
appointed Shawn Stewart as Chief Executive Officer and director of the Company, effective April 28, 2024
Effective April 24, 2024, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Julius Ivancsits to serve as Chief Financial Officer of the Company.
Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
William Hisey – Interim CEO Appointment: On April 24, 2024, Avant Technologies, Inc. (the 'Company') and William Hisey entered into an Employment Agreement pursuant to which Mr. Hisey was retained as Interim Chief Executive Officer ('CEO').
On April 23, 2024, Deborah Knobelman, Ph.D., the Chief Financial Officer, Treasurer and Head of Corporate Development of Senti Biosciences Inc. (“the Company”) and its principal financial officer and principal accounting officer, notified the Company of her decision to resign from her employment with the Company, effective May 3, 2024.
Brian Coad was appointed as a director and Chief Financial Officer
Suresh Guduru was appointed as Chairman and Chief Executive Officer
On April 19, 2024, Diebold Nixdorf, Incorporated (the “Company”) agreed to an offer letter (the “Offer Letter”) with Thomas S. Timko, pursuant to which Mr. Timko has agreed to serve as Executive Vice President and Chief Financial Officer of the Company.
On April 25, 2024, Talos Energy Inc. (the “ Company ”) announced the promotion of Sergio L. Maiworm, Jr., from Senior Vice President and Chief Financial Officer to Executive Vice President and Chief Financial Officer, effective April 24, 2024.
On April 23, 2024, Jonathan S. Lock resigned from all positions with The Chemours Company (the “Company”).
On April 25, 2024 Joseph E. Duey, the Company’s Chief Financial Officer, resigned, effective as of April 30, 2024.
Vincent Browne, the Company’s Chief Executive Officer, will act as interim Chief Financial Officer.
Mr. Hayes succeeds Christian Fong, whose separation from the Company and resignation as a director is effective as of the Transition Date.
On April 12, 2024, the Board of Directors of the Company appointed Mr. Christopher Hayes, as Chief Executive Officer and President of the Company, effective April 12, 2024
The Company also announced that Timothy Cofer has been appointed as Chief Executive Officer and as a member of the Board, effective April 26, 2024.
On April 10, 2024, Carla A. Leibold’s employment as Executive Vice President and Chief Financial Officer of the Company terminated.
Carla A. Leibold, who had served as the Company’s Executive Vice President and Chief Financial Officer from November 2018 through April 10, 2024
At the effective date of transfer, Malik Sherray Lee consented to act as the new President, CEO, and Chairman of the Board of Directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.